Sanctuary Advisors LLC raised its holdings in The Clorox Company (NYSE:CLX – Free Report) by 47.8% in the 1st quarter, Holdings Channel reports. The institutional investor owned 20,248 shares of the company’s stock after acquiring an additional 6,553 shares during the period. Sanctuary Advisors LLC’s holdings in Clorox were worth $2,098,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Darwin Wealth Management LLC acquired a new position in Clorox during the second quarter worth approximately $29,000. Caitlin John LLC boosted its holdings in shares of Clorox by 1,807.1% in the 4th quarter. Caitlin John LLC now owns 267 shares of the company’s stock valued at $27,000 after purchasing an additional 253 shares during the last quarter. Root Financial Partners LLC grew its stake in shares of Clorox by 83.8% during the 1st quarter. Root Financial Partners LLC now owns 318 shares of the company’s stock valued at $33,000 after buying an additional 145 shares during the period. Vision Financial Markets LLC grew its stake in shares of Clorox by 166.7% during the 4th quarter. Vision Financial Markets LLC now owns 320 shares of the company’s stock valued at $32,000 after buying an additional 200 shares during the period. Finally, SHP Wealth Management acquired a new stake in shares of Clorox during the 4th quarter worth $35,000. Institutional investors and hedge funds own 78.53% of the company’s stock.
Insider Buying and Selling at Clorox
In other Clorox news, Director Pierre R. Breber bought 5,000 shares of the company’s stock in a transaction dated Tuesday, May 5th. The shares were acquired at an average cost of $85.82 per share, with a total value of $429,100.00. Following the completion of the transaction, the director owned 18,000 shares in the company, valued at $1,544,760. The trade was a 38.46% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.63% of the stock is owned by corporate insiders.
Clorox Trading Down 0.6%
Clorox (NYSE:CLX – Get Free Report) last announced its earnings results on Thursday, April 30th. The company reported $1.64 earnings per share for the quarter, beating the consensus estimate of $1.55 by $0.09. The business had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.67 billion. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The business’s quarterly revenue was up .1% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.45 earnings per share. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Analysts expect that The Clorox Company will post 5.52 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
Several research analysts recently weighed in on CLX shares. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and issued a $91.00 target price on shares of Clorox in a research report on Friday, May 1st. Evercore restated an “underperform” rating and set a $110.00 price target on shares of Clorox in a research note on Friday, May 1st. UBS Group raised their price objective on Clorox from $96.00 to $100.00 and gave the stock a “neutral” rating in a report on Thursday, July 16th. TD Cowen lifted their price objective on Clorox from $98.00 to $111.00 and gave the company a “hold” rating in a research note on Tuesday, March 31st. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Clorox in a report on Friday, July 10th. One investment analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and five have given a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Reduce” and an average price target of $103.40.
Read Our Latest Stock Analysis on CLX
Clorox Company Profile
The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.
Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.
See Also
- Five stocks we like better than Clorox
- Confidence Is Back, But Earnings Show the Consumer Is Being Picky
- AeroVironment’s Stock Is Down, But Drone Demand Is Taking Off
- 3M’s Redemption Arc: Can Q2 Earnings Change the Narrative?
- 3 Photonics Companies Making Quantum Tech Possible
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
